Abstract Details

Title Real-World Assessment of Adherence and Persistence to Second-Line Disease-Modifying Therapies among Multiple Sclerosis Patients

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 156

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Rachel Halpern, PhD	No disclosure on file
Carl A. Gold, MD, FAAN (Stanford University)	Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a CME Course Presenter with Oakstone.
	No disclosure on file
	No disclosure on file
Tomislav Babic	No disclosure on file
Elizabeth R. DeGrush, DO (University of Massachusetts Medical School)	Dr. DeGrush has nothing to disclose.

��ɫ��